Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, as monotherapy in epidermal growth factor receptor (EGFR) amplified, recurrent glioblastoma (GBM).
暂无分享，去创建一个
T. Mikkelsen | N. Butowski | M. Bent | D. Reardon | A. Lassman | J. Simes | K. Papadopoulos | H. Wheeler | H. Xiong | H. Gan | M. Penas-Prado | R. Merrell | E. Bain | K. Holen | Z. Lwin | L. Nabors | P. Kumthekar | Ho-Jin Lee | L. Roberts-Rapp | E. Gomez